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Abstract
Primary pleural angiosarcoma is a rare and clinically aggressive tumor. Patients usually present with chest pain,
dyspnea, hemoptysis and/or cough. Radiologic studies reveal diffuse pleural thickening and pleural effusion with or
without mass lesion. The clinical and radiological features both resemble those of mesothelioma, and its definite
diagnosis requires careful histologic examination. However, frequent epithelioid feature and immunoreactivity to
cytokeratin in primary pleural angiosarcoma further complicate the pathologic diagnosis. The use of proper
immunohistochemical stains is often needed to support endothelial differentiation in the tumor cells and to
exclude metastatic carcinoma and mesothelioma. We report the case of a 49-year-old male patient with primary
pleural angiosarcoma, who presented with initial hemothorax, followed by a rapid progress to an inoperable status.
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Background
Angiosarcoma is an uncommon malignant tumor of
endothelial differentiation. It accounts for about 1% of
all soft tissue malignancies and most commonly arises
in skin, soft tissue, breast, liver, bone and spleen [1].
Primary pleural angiosarcoma (PPA) is a rare occur-
rence. Since its first description in 1943,[2] only 39
reported cases of PPA have been published [1-22].
Patients almost always die of the disease within months.
Definite diagnosis is usually not possible using the
examination of cytology or small biopsy specimens, but
often requires that of decortication or resection speci-
mens. The histologic picture of biphasic spindle and
epithelioid tumor cells along with immunoreactivity to
epithelial markers, such as cytokeratin and CK7, may
lead to an erroneous diagnosis of mesothelioma or
metastatic sarcomatoid carcinoma. Identifying areas
showing vasoformative tendency and immunostains with
endothelial markers, such as CD31, CD34, factor VIII
and FLI-1, are diagnostically important.
We describe herein a case of PPA, to highlight its
aggressive clinical behavior and the diagnostic pitfalls.
Case presentation
Clinical summary
A 49 year-old-male patient presented with intermittent
right chest pain for one month. The pain progressed
with exertional dyspnea. He had a 10-year history of
asthma under regular medical treatment and was an ex-
smoker (half package-per-day for 20 years in the past)
who quit 10 years ago. He did not have any history of
asbestos exposure or tuberculous infection. In physical
examination, breathing sounds were decreased at the
right lung. Chest radiography and computed tomogra-
phy revealed right-side loculated pleural effusion with
pleural thickening but without mass lesion (Figure 1).
Fine needle aspiration showed some bloody and sticky
pleural effusion. The value of hematocrit of the effusion
was 39.5% (peripheral blood hematocrit: 38.9%). Cytolo-
gic examination of the pleural effusion showed negative
for malignancy. Thoracoscopic examination revealed dif-
fuse blood clot coating and thickening of the visceral
and parietal pleura over the right hemithorax. He
received thoracoscopic decortication of the pleura. Sub-
sequent staging image series showed no evidence of
metastatic lesion in brain, bone and lung.
One month later, open thoracotomy revealed tumor
mass extending along the previous surgical wound and
encasing the right pulmonary hilum. Curative resection * Correspondence: chencl@tmu.edu.tw
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sional biopsy of the tumor.
Pathologic findings
Histologically, the specimens showed an extensive
hemorrhagic background with epithelioid tumor cells
arranged in solid sheets and discohesive cells separated
by abundant red blood cells (RBCs) (Figure 2A-B). Infil-
trative growth of the tumor cells in a hyalinized to
fibrous background and between skeletal muscles was
also present. The tumor cells had pleomorphic nuclei,
irregular nuclear contour, occasional binucleation, vesi-
cular chromatin, prominent nucleoli and abundant eosi-
nophilic cytoplasm, giving an epithelioid feature.
Rudimentary and anastomosing vascular channels and
Intracytoplasmic lumens containing RBCs were seen in
areas (Figure 2C-D). Spindle tumor cells were observed
as a minor component of the tumor. The results of
immunohistochemical stains showed diffuse positive
staining for CD31, FLI-1, cytokeratin (AE1/AE3) and
CK7 (Figure 3A-B), whereas CD34, factor VIII, and
mesothelial markers including calretinin, CK5/6, HBME-
1, and WT-1 were negative. An angiosarcoma was diag-
nosed. The patient then received radiotherapy (3750
cGy with 15 fractions), five cycles of chemotherapy with
mesna, ifosfamide, doxorubicin and dacarbazine, two
cycles of cisplatin and doxorubicin and three cycles of
doxorubicin, etoposide and thalidomide. He was alive
with the disease nine months after the diagnosis was
made.
Discussion
PPA is an aggressive and rapidly fatal disease. Only 39
cases have been reported in the literature[1-22] after
excluding epithelioid hemangioendothelioma. Together
with our patient, the ages of the patients ranged from
33 to 79 years (mean: 59.1 years) with male predomi-
nance (4:1, Figure 4). The most common presentation is
chest pain (47.5%), followed by dyspnea (35%), hemopty-
sis (27.5%), cough (15%) and weight loss (10%). Radiolo-
gic examinations usually show unilateral or bilateral
effusion (70%) and diffuse pleural thickening (40%),
simulating the presentation of mesothelioma. Mass
lesions are seen in about half of the patients (54.3%)
[2-7,9,10,14,20-22].
The effusions are usually bloody. Cytologic examina-
tion of the pleural effusion is rarely helpful in making
the diagnosis. In the seven cases with available cytologic
examination results,[1,8,9,13,19,20,22] presence of atypi-
cal cells was described in only one case [20]. Most
patients were diagnosed by surgical excision (32.5%,
including debulking excision, pleurectomy and decorti-
cation) [3,5,7,9,12,13,15,17,18,20] or autopsy in rapidly
lethal cases (27.5%) [2,4,5,8,10,21,22]. Using non-invasive
biopsy and surgical biopsy, the patients were diagnosed
as PPA in a smaller proportion of cases (17.5% and 10%,
respectively) [1,5,6,14,16,19]. Six out of 40 patients
received a non-diagnostic biopsy [8,9,13,19,21,22]. Thus,
in the context of refractory bloody pleural effusion of
uncertain etiology, we suggest that surgical biopsy or
excision should be considered even without mass lesion.
The histologic features show malignant spindle and/or
epithelioid neoplasm with areas of vasoformative nature,
such as vascular spaces lined by atypical tumor cells and
intracytoplasmic lumen containing RBCs. Epithelioid
features were mentioned in the majority of cases (72.5%)
and constituted variable proportion of the tumors
[1,5-15,17-19]. The differential diagnosis of a biphasic
pleural tumor mainly includes mesothelioma and sarco-
matoid carcinoma. In general, mesothelioma shows
more monotonous tumor cells with less degree of cyto-
logic atypia. Intracytoplasmic lumen can be seen both in
angiosarcoma and mesothelioma, but intraluminal RBCs
are not seen in mesotheliomas [11]. Sarcomatoid carci-
noma less likely manifests as diffuse pleural involve-
ment. The carcinomatous component and clinical
history would aid in diagnosis.
Immunohistochemical stains have an important role in
differential diagnosis. Expression of at least one of the
endothelial markers including CD31, CD34, factor VIII
and FLI-1, is required to confirm the diagnosis of angio-
sarcoma. Among them, CD31 is considered to be the
most sensitive and specific [1]. Epithelial markers can be
expressed in angiosarcoma, especially in the epithelioid
variant [23]. Positive cytokeratin staining was found in
60.9% cases of PPA (14 of 23, including our patient)
[1,5,11,14,15]. Immunoreactivity to CAM5.2, CK7, CK8
or CK18 has also been reported [1,13,14]. Epithelial
Figure 1 Chest roentgenogram. Plain chest film showed right-side
loculated pleural effusion.
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with available results [5,6,12,16,19,20]. The expression of
epithelial markers can be misleading in pathologic diag-
nosis. One should bear in mind that cytokeratin is also
frequently expressed in epithelioid vascular tumors.
Although the expression pattern of cytokeratin can
range from diffuse and strong to focal and weak in dis-
tribution, it is usually not as strong as that in carcinoma
or mesothelioma [17]. Mesothelial markers such as cal-
retinin, CK5/6, HBME-1 and WT-1, are used to exclude
malignant mesothelioma.
The etiologic factors in most cases of PPA are still
unknown. Some case reports from Japan indicated the
relationship with tuberculous pyothorax (n = 11),
[5,15,21] while some cases from western countries had
history of asbestos exposure (n = 4)[7,10] or radiother-
apy (n = 1) [11]. Association with tuberculosis has been
first described by Myoui et al. in 3 out of 4 PPA patients
[24]. Based on a series of autopsy cases, Aozasa et al.
later reported six additional PPA patients associated
with tuberculosis and postulated 3,600-fold increased
risk of PPA in pyothorax patients [5]. But, Hattori et al.
suggested that pyothorax-associated angiosarcoma often
manifest as chest wall soft tissue tumors instead of dif-
fuse pleural involvement and should be separated from
PPA [25]. Attanoos et al reported three PPA patients
with history of asbestos exposure [10]. However, only
one of them had typical asbestos bodies in the lung and
increased asbestos fiber content by mineral analysis.
O n ep a t i e n tw i t hh i s t o r yo fp revious radiotherapy for
ovarian carcinoma developed simultaneous pleural and
peritoneal angiosarcoma [11]. Our patient did not have
any history of tuberculosis, asbestos exposure or
radiotherapy.
The treatments of angiosarcoma include surgical exci-
sion, radiotherapy and/or chemotherapy. However, the
clinical course is usually rapidly fatal, regardless of treat-
ment modalities. Seventy percent of the patients died of
Figure 2 Histomorphology of the decortication specimen. Pleural angiosarcoma with scattered tumor cells in the hemorrhagic background
(A). Solid sheets of epithelioid tumor cells can simulate mesothelioma and/or carcinoma (B). Intracytoplasmic lumen containing red blood cells
(C, arrowhead) and anastomosing vascular spaces (D) are evidence of endothelial differentiation (hematoxylin-eosin, ×200 [A, D] and ×400 [B, C]).
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even worse than angiosarcoma of other organs [23].
According to the occurring frequency, metastatic sites
reported in the literature include lymph node, adrenal
gland, bone, brain, oral cavity, liver, skin, spleen, gastro-
intestinal tract, kidney and spinal cord [2,3,5,8,15,18,19].
In addition to nodal metastasis (n = 6) as in epithelioid
angiosarcoma of other organs,[23] autopsied cases of
PPA reported by Aozasa et al. show preference of adre-
nal gland metastasis (n = 5) [5].
Conclusion
In conclusion, PPA is a highly malignant disease, which
may mimic mesothelioma clinically, radiologically and
even pathologically. The diagnostic pitfalls include
mesotheliomatous growth pattern with diffuse pleural
involvement, biphasic histomorphologic pattern and
immunoreactivity to cytokeratin. An accurate diagnosis
requires careful pathologic examination to identify the
evidence of endothelial differentiation aided with immu-
nohistochemical stains.
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Figure 3 Immunohistochemical stains. Diffuse CD31 positivity (A)
indicates the vascular nature of the tumor cells. Diffuse
immunoreactivity for cytokeratin stain (B) could be a diagnostic
pitfall. (×400 [A] and ×200 [B]).
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Figure 4 Age and sex distribution of reported cases of primary
pleural angiosarcoma. Male predominance was shown in the age
group of 40-79 years.
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Figure 5 Survival length of reported available 34 cases of
primary pleural angiosarcoma. Most patients died of disease
within several months, and all of them died by the end of 24
months.
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